c-Src, receptor tyrosine kinases, and human cancer.

[1]  S. Parsons,et al.  Characterization of human epidermal growth factor receptor and c‐Src interactions in human breast tumor cells , 1998, Molecular carcinogenesis.

[2]  A. Bardelli,et al.  Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.

[3]  R. B. Montgomery,et al.  Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor* , 1998, The Journal of Biological Chemistry.

[4]  Hua Yu,et al.  Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential , 1997, Oncogene.

[5]  S. Ménard,et al.  A point mutation in the MET oncogene abrogates metastasis without affecting transformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Uchida,et al.  Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tryosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4 , 1997, Oncogene.

[7]  E. Hudson,et al.  Met and hepatocyte growth factor/scatter factor expression in human gliomas. , 1997, Cancer research.

[8]  M. Lisanti,et al.  Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins , 1997, The Journal of Biological Chemistry.

[9]  S J Parsons,et al.  Overexpression of Cellular Src in Fibroblasts Enhances Endocytic Internalization of Epidermal Growth Factor Receptor* , 1997, The Journal of Biological Chemistry.

[10]  L. Schmidt,et al.  Activating mutations for the met tyrosine kinase receptor in human cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Rohrschneider,et al.  Sequential activation of phoshatidylinositol 3‐kinase and phospholipase C‐γ2 by the M‐CSF receptor is necessary for differentiation signaling , 1997, The EMBO journal.

[12]  J. Chernoff,et al.  Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. , 1997, The Biochemical journal.

[13]  E. Vadai,et al.  Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells , 1997, Oncogene.

[14]  S. Hubbard.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.

[15]  N. Tonks,et al.  Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition , 1997, Oncogene.

[16]  Helen L. Yin,et al.  The Actin Cytoskeleton Is Required for Receptor-mediated Endocytosis in Mammalian Cells* , 1997, The Journal of Biological Chemistry.

[17]  M L van Hoek,et al.  Phosphotyrosine phosphatase activity associated with c-Src in large multimeric complexes isolated from adrenal medullary chromaffin cells. , 1997, The Biochemical journal.

[18]  K. Barker,et al.  BRK tyrosine kinase expression in a high proportion of human breast carcinomas , 1997, Oncogene.

[19]  B. Katzenellenbogen,et al.  Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. , 1997, Molecular endocrinology.

[20]  Philippe Soriano.  The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. , 1997, Development.

[21]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[22]  Charles C. Wykoff,et al.  Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth* , 1997, The Journal of Biological Chemistry.

[23]  R. Halaban,et al.  Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases , 1997, Oncogene.

[24]  H. Miyake,et al.  Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. , 1997, The Journal of urology.

[25]  T. Magnuson,et al.  Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. , 1997, The American journal of pathology.

[26]  J. Madri,et al.  Platelet Endothelial Cell Adhesion Molecule-1 Is Phosphorylatable by c-Src, Binds Src-Src homology 2 Domain, and Exhibits Immunoreceptor Tyrosine-based Activation Motif-like Properties* , 1997, The Journal of Biological Chemistry.

[27]  T. Hunter,et al.  Focal Adhesion Kinase Overexpression Enhances Ras-dependent Integrin Signaling to ERK2/Mitogen-activated Protein Kinase through Interactions with and Activation of c-Src* , 1997, The Journal of Biological Chemistry.

[28]  J. Geng,et al.  Adhesion of HT‐29 colon carcinoma cells to E‐selectin results in increased tyrosine phosphorylation and decreased activity of c‐src , 1997, International journal of cancer.

[29]  B. Imhof,et al.  Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. , 1997, The American journal of pathology.

[30]  A. Aguzzi,et al.  Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice , 1997, Oncogene.

[31]  S. Scherer,et al.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.

[32]  P. Schlesinger,et al.  Substrate Recognition by Osteoclast Precursors Induces C-src/Microtubule Association , 1997, The Journal of cell biology.

[33]  J. Parsons,et al.  Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. , 1997, Current opinion in cell biology.

[34]  E. Schuuring,et al.  Markers for assessment of nodal metastasis in laryngeal carcinoma. , 1997, Archives of otolaryngology--head & neck surgery.

[35]  J. DiGiovanni,et al.  Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion , 1997, Oncogene.

[36]  E. Schuuring,et al.  The Redistribution of Cortactin into Cell-Matrix Contact Sites in Human Carcinoma Cells with 11q13 Amplification Is Associated with Both Overexpression and Post-translational Modification* , 1997, The Journal of Biological Chemistry.

[37]  J. Bos,et al.  Cell scattering of SK-N-MC neuroepithelioma cells in response to Ret and FGF receptor tyrosine kinase activation is correlated with sustained ERK2 activation , 1997, Oncogene.

[38]  M. Göke,et al.  Signal Transduction Pathway of Human Fibroblast Growth Factor Receptor 3 , 1997, The Journal of Biological Chemistry.

[39]  G. Gallick,et al.  Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[40]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[41]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[42]  J. Settleman,et al.  Tandem SH2 binding sites mediate the RasGAP–RhoGAP interaction: a conformational mechanism for SH3 domain regulation , 1997, The EMBO journal.

[43]  M. Omary,et al.  Src activation in malignant and premalignant epithelia of Barrett's esophagus. , 1997, Gastroenterology.

[44]  A. Ullrich,et al.  Novel mechanisms of RTK signal generation. , 1997, Current opinion in genetics & development.

[45]  Xian-Min Yu,et al.  NMDA Channel Regulation by Channel-Associated Protein Tyrosine Kinase Src , 1997, Science.

[46]  B. Ozanne,et al.  A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer , 1997, Oncogene.

[47]  T. Waldmann,et al.  Effects of the tyrosine‐kinase inhibitor geldanamycin on ligand‐induced HER‐2/NEU activation, receptor expression and proliferation of HER‐2‐positive malignant cell lines , 1997, International journal of cancer.

[48]  T. Hunter,et al.  The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding , 1997, Oncogene.

[49]  Michael C. Ostrowski,et al.  Regulation of CSF‐1 receptor expression , 1997, Molecular reproduction and development.

[50]  R. Baron,et al.  Role of c‐Src in cellular events associated with colony‐stimulating factor‐1‐induced spreading in osteoclasts , 1997, Molecular reproduction and development.

[51]  I. Levitan,et al.  Association of Src Tyrosine Kinase with a Human Potassium Channel Mediated by SH3 Domain , 1996, Science.

[52]  U. Novak,et al.  Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for STAT1 activation in response to CSF-1. , 1996, Oncogene.

[53]  R. Salgia,et al.  The Related Adhesion Focal Tyrosine Kinase Forms a Complex with Paxillin in Hematopoietic Cells* , 1996, The Journal of Biological Chemistry.

[54]  V. Schirrmacher,et al.  Induction of apoptosis by EGF receptor in rat mammary adenocarcinoma cells coincides with enhanced spontaneous tumour metastasis. , 1996, Oncogene.

[55]  Hiroto Yamaguchi,et al.  Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation , 1996, Nature.

[56]  G. Rijksen,et al.  c‐Src PROTEIN EXPRESSION IS INCREASED IN HUMAN BREAST CANCER. AN IMMUNOHISTOCHEMICAL AND BIOCHEMICAL ANALYSIS , 1996, The Journal of pathology.

[57]  H. Antoniades,et al.  Expression of platelet‐derived growth factor (PDGF)‐A, PDGF‐B and the PDGF‐alpha receptor, but not the PDGF‐beta receptor, in human malignant melanoma in vivo , 1996, The British journal of dermatology.

[58]  C. Heldin,et al.  Grb7 is a Downstream Signaling Component of Platelet-derived Growth Factor α- and β-Receptors* , 1996, The Journal of Biological Chemistry.

[59]  B. Gusterson,et al.  Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.

[60]  A. deFazio,et al.  Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines , 1996, International journal of cancer.

[61]  M. Lisanti,et al.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. , 1996, The Journal of biological chemistry.

[62]  J. Madri,et al.  Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[63]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[64]  A. Bilancio,et al.  Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. , 1996, Cancer research.

[65]  M. Klagsbrun,et al.  Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.

[66]  C. Wernstedt,et al.  Mutation of a Src phosphorylation site in the PDGF beta‐receptor leads to increased PDGF‐stimulated chemotaxis but decreased mitogenesis. , 1996, The EMBO journal.

[67]  D T Denhardt,et al.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. , 1996, The Biochemical journal.

[68]  V. Tkachuk,et al.  REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING , 1996, Clinical and experimental pharmacology & physiology.

[69]  P. Jeffrey,et al.  Characterization of two distinct populations of detergent resistant membrane complexes isolated from chick brain tissues , 1996, Journal of neuroscience research.

[70]  G. V. Vande Woude,et al.  Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. , 1996, Oncogene.

[71]  J. Capeau,et al.  Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. , 1996, British Journal of Cancer.

[72]  P. Jeffrey,et al.  Structural basis of cyclin-dependent kinase activation by phosphorylation , 1996, Nature Structural Biology.

[73]  D. Rifkin,et al.  Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals. , 1996, Cancer research.

[74]  A. Zallone,et al.  Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[75]  T. Hunter,et al.  Requirement for c-Src Catalytic Activity and the SH3 Domain in Platelet-derived Growth Factor BB and Epidermal Growth Factor Mitogenic Signaling* , 1996, The Journal of Biological Chemistry.

[76]  S. Courtneidge,et al.  The Src SH3 Domain Is Required for DNA Synthesis Induced by Platelet-derived Growth Factor and Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.

[77]  R. Yarden,et al.  Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. , 1996, Endocrinology.

[78]  M. Moran,et al.  Requirement for the Adapter Protein GRB2 in EGF Receptor Endocytosis , 1996, Science.

[79]  J. Parsons,et al.  p130Cas, a Substrate Associated with v-Src and v-Crk, Localizes to Focal Adhesions and Binds to Focal Adhesion Kinase* , 1996, The Journal of Biological Chemistry.

[80]  M. T. Brown,et al.  Regulation, substrates and functions of src. , 1996, Biochimica et biophysica acta.

[81]  C. Zandonella,et al.  Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. , 1996, Cancer research.

[82]  Y. Yazaki,et al.  Src kinase plays an essential role in integrin-mediated tyrosine phosphorylation of Crk-associated substrate p130Cas. , 1996, Biochemical and biophysical research communications.

[83]  D. Picard,et al.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. , 1996, The EMBO journal.

[84]  R. Goodman,et al.  Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. , 1996, The Journal of clinical investigation.

[85]  K. Ozawa,et al.  Direct Binding of C-terminal Region of p130 to SH2 and SH3 Domains of Src Kinase (*) , 1996, The Journal of Biological Chemistry.

[86]  S. Hanks,et al.  Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells. , 1996, Cancer biochemistry biophysics.

[87]  C. Humblet,et al.  Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain. , 1996, Drug design and discovery.

[88]  L. Akslen,et al.  Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. , 1996, Cancer research.

[89]  Y. Liu,et al.  Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein. , 1996, Oncogene.

[90]  Y. Yarden,et al.  Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. , 1996, Oncogene.

[91]  M. Pagano,et al.  A 67 kDa non‐hormone binding estradiol receptor is present in human mammary cancers , 1996 .

[92]  C. Wernstedt,et al.  Structural Determinants in the Platelet-derived Growth Factor -Receptor Implicated in Modulation of Chemotaxis (*) , 1996, The Journal of Biological Chemistry.

[93]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[94]  G. V. Vande Woude,et al.  Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network , 1996, Molecular and cellular biology.

[95]  P. Drake,et al.  Intracellular signal transduction: The role of endosomes , 1996, Trends in Endocrinology & Metabolism.

[96]  M. Lisanti,et al.  Phosphorylation of Caveolin by Src Tyrosine Kinases , 1996, The Journal of Biological Chemistry.

[97]  Y. Nakamura,et al.  Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. , 1996, Oncogene.

[98]  M. Jalkanen,et al.  The role of syndecan-1 in malignancies. , 1996, Annals of medicine.

[99]  T. H. van der Kwast,et al.  EXPRESSION OF PLATELET‐DERIVED GROWTH FACTOR (PDGF) AND PDGF RECEPTORS IN HUMAN MALIGNANT MESOTHELIOMA IN VITRO AND IN VIVO , 1996, The Journal of pathology.

[100]  Y. Yarden,et al.  Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. , 1996, The American journal of pathology.

[101]  W. Symmans,et al.  Transfected neu oncogene induces human prostate cancer metastasis , 1996, The Prostate.

[102]  T. van Raaij,et al.  Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. , 1996, Oncogene.

[103]  A. Frackelton,et al.  Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway , 1996, International journal of cancer.

[104]  O. Potapova,et al.  Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. , 1996, Cancer research.

[105]  Jonathan A. Cooper,et al.  Differential Modulation of Mitogen-activated Protein (MAP) Kinase/Extracellular Signal-related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor Receptor (*) , 1995, The Journal of Biological Chemistry.

[106]  D. Mukhopadhyay,et al.  Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. , 1995, Cancer research.

[107]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[108]  D. Vorojeikina,et al.  Phosphorylation of Tyrosine 537 on the Human Estrogen Receptor Is Required for Binding to an Estrogen Response Element (*) , 1995, The Journal of Biological Chemistry.

[109]  J. Biegel,et al.  Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. , 1995, Cancer research.

[110]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[111]  M. Barone,et al.  Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src , 1995, Nature.

[112]  Carmen Birchmeier,et al.  Multiple essential functions of neuregulin in development , 1995, Nature.

[113]  Kuo-Fen Lee,et al.  Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.

[114]  Rüdiger Klein,et al.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.

[115]  R. Lupu,et al.  Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells , 1995, International journal of cancer.

[116]  S. Hanks,et al.  Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[117]  M. Resh,et al.  p80/85 Cortactin Associates with the Src SH2 Domain and Colocalizes with v-Src in Transformed Cells (*) , 1995, The Journal of Biological Chemistry.

[118]  T. Smithgall,et al.  SH2 and SH3 domains: potential targets for anti-cancer drug design. , 1995, Journal of pharmacological and toxicological methods.

[119]  J. Martín-Pérez,et al.  Prolactin receptor is associated with c-src kinase in rat liver. , 1995, Molecular endocrinology.

[120]  Y. Fukami,et al.  c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. , 1995, Biochemical and biophysical research communications.

[121]  S. Kanda,et al.  Shc and a Novel 89-kDa Component Couple to the Grb2-Sos Complex in Fibroblast Growth Factor-2-stimulated Cells (*) , 1995, The Journal of Biological Chemistry.

[122]  H. DeLisser,et al.  Alternative Splicing of a Specific Cytoplasmic Exon Alters the Binding Characteristics of Murine Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1) (*) , 1995, The Journal of Biological Chemistry.

[123]  D. Hume,et al.  Regulation of the c-fms promoter in murine tumour cell lines. , 1995, Oncogene.

[124]  C. Betsholtz.  Role of platelet-derived growth factors in mouse development. , 1995, The International journal of developmental biology.

[125]  D. Lappi.  Tumor targeting through fibroblast growth factor receptors. , 1995, Seminars in cancer biology.

[126]  H. Friess,et al.  Induction of platelet‐derived growth factor A and B chains and over‐expression of their receptors in human pancreatic cancer , 1995, International journal of cancer.

[127]  E. Krebs,et al.  Platelet‐derived Growth Factor , 1995 .

[128]  R. Cardiff,et al.  Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[129]  G. Scambia,et al.  Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. , 1995, British Journal of Cancer.

[130]  A. Tanswell,et al.  PDGF-AA and its receptor influence early lung branching via an epithelial-mesenchymal interaction. , 1995, Development.

[131]  S. F. Arnold,et al.  An antiestrogen: a phosphotyrosyl peptide that blocks dimerization of the human estrogen receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. Jove,et al.  Two SH2 Domains of p120 Ras GTPase-activating Protein Bind Synergistically to Tyrosine Phosphorylated p190 Rho GTPase-activating Protein (*) , 1995, The Journal of Biological Chemistry.

[133]  W. Muller,et al.  Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. , 1995, Oncogene.

[134]  M. Maa,et al.  Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[135]  K. Malarkey,et al.  The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. , 1995, The Biochemical journal.

[136]  N. Rosen,et al.  Herbimycin A Induces the 20 S Proteasome- and Ubiquitindependent Degradation of Receptor Tyrosine Kinases (*) , 1995, The Journal of Biological Chemistry.

[137]  J. Settleman,et al.  c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation , 1995, The Journal of cell biology.

[138]  G. Maul,et al.  Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment , 1995, The Journal of cell biology.

[139]  Sheila M. Thomas,et al.  Specific and redundant roles of Src and Fyn in organizing the cytoskeleton , 1995, Nature.

[140]  M. Gaffey,et al.  Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. , 1995, Archives of otolaryngology--head & neck surgery.

[141]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[142]  N. Lydon,et al.  Src Phosphorylation of the Epidermal Growth Factor Receptor at Novel Sites Mediates Receptor Interaction with Src and P85α (*) , 1995, The Journal of Biological Chemistry.

[143]  M. Lisanti,et al.  Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin , 1995, The Journal of Biological Chemistry.

[144]  Y. Yazaki,et al.  Integrin-mediated Cell Adhesion Promotes Tyrosine Phosphorylation of p130, a Src Homology 3-containing Molecule Having Multiple Src Homology 2-binding Motifs (*) , 1995, The Journal of Biological Chemistry.

[145]  W. Whelan,et al.  Catalytic Activities of Glycogenin Additional to Autocatalytic Self-glucosylation (*) , 1995, The Journal of Biological Chemistry.

[146]  M. Sliwkowski,et al.  HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. , 1995, Oncogene.

[147]  D. Mukhopadhyay,et al.  Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation , 1995, Nature.

[148]  A. Gown,et al.  Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. , 1995, Cancer research.

[149]  H. Varmus,et al.  c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. , 1995, Genes & development.

[150]  M. Schartl,et al.  Association between the melanoma-inducing receptor tyrosine kinase Xmrk and src family tyrosine kinases in Xiphophorus. , 1995, Oncogene.

[151]  A. Ullrich,et al.  Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells. , 1995, Oncogene.

[152]  J. Slavin,et al.  Fibroblast growth factors: at the heart of angiogenesis. , 1995, Cell biology international.

[153]  M. Koegl,et al.  Sequence Requirements for Binding of Src Family Tyrosine Kinases to Activated Growth Factor Receptors (*) , 1995, The Journal of Biological Chemistry.

[154]  M. Kan,et al.  Ligand-specific Structural Domains in the Fibroblast Growth Factor Receptor (*) , 1995, The Journal of Biological Chemistry.

[155]  K. Ohashi,et al.  Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase. , 1995, Biochemical and biophysical research communications.

[156]  F. Bertucci,et al.  Expression of fgf and fgf receptor genes in human breast cancer , 1995, International journal of cancer.

[157]  S. Bockholt,et al.  Adhesion-induced tyrosine phosphorylation of the p130 src substrate. , 1995, Journal of cell science.

[158]  O. Majdic,et al.  Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes , 1995, The Journal of experimental medicine.

[159]  A. Levitzki,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Science.

[160]  R. Coombes,et al.  bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement. , 1995, The Biochemical journal.

[161]  D. Baltimore,et al.  Reduction of caveolin and caveolae in oncogenically transformed cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[162]  S. Matsuda,et al.  Expression of C-terminal src kinase in human colorectal cancer cell lines. , 1995, Japanese journal of clinical oncology.

[163]  M. Roussel,et al.  DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases , 1995, Molecular and cellular biology.

[164]  L. Brizuela,et al.  Induction of interleukin‐2 transcription by the hamster polyomavirus middle T antigen: a role for Fyn in T cell signal transduction , 1995, European journal of immunology.

[165]  P. Kloetzel,et al.  Developmental Changes of the 26 S Proteasome in Abdominal Intersegmental Muscles of Manduca sexta during Programmed Cell Death (*) , 1995, The Journal of Biological Chemistry.

[166]  Larry J. Shampine,et al.  Peptide inhibitors of src SH3-SH2-phosphoprotein interactions. , 1995, The Journal of biological chemistry.

[167]  N. Hynes,et al.  The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.

[168]  K. Matsumoto,et al.  Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. , 1994, The Journal of biological chemistry.

[169]  S. Aizawa,et al.  Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells. , 1994, Oncogene.

[170]  K. Alitalo,et al.  Rak, a novel nuclear tyrosine kinase expressed in epithelial cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[171]  T. Seufferlein,et al.  Sphingosine induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. , 1994, The Journal of biological chemistry.

[172]  A. Levitzki,et al.  Epidermal-growth-factor-dependent activation of the src-family kinases. , 1994, European journal of biochemistry.

[173]  A. Green,et al.  Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes , 1994 .

[174]  N. Martinet,et al.  The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. , 1994, Cancer research.

[175]  G. Staal,et al.  Functional interaction between the epidermal growth factor receptor and c‐Src kinase activity , 1994, FEBS letters.

[176]  H. Varmus,et al.  Association of the amino‐terminal half of c‐Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. , 1994, The EMBO journal.

[177]  S. Fumagalli,et al.  A mitotic function for Src? , 1994, Trends in cell biology.

[178]  S. Thorgeirsson,et al.  The high transforming potency of erbB-2 and ret is associated with phosphorylation of paxillin and a 23 kDa protein. , 1994, Oncogene.

[179]  J. Parsons,et al.  Focal adhesion kinase and associated proteins. , 1994, Current opinion in cell biology.

[180]  P. Hollings.  Molecular heterogeneity at the breakpoints of smaller 20q deletions , 1994, Genes, chromosomes & cancer.

[181]  G. M. Di Guglielmo,et al.  Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf‐1 by EGF but not insulin in liver parenchyma. , 1994, The EMBO journal.

[182]  R. Friesel,et al.  Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. , 1994, The Journal of biological chemistry.

[183]  V. P. Collins,et al.  Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. , 1994, Oncogene.

[184]  K. Rothberg,et al.  Purification and characterization of smooth muscle cell caveolae , 1994, The Journal of cell biology.

[185]  R. Carroll,et al.  Messenger ribonucleic acid expression of platelet-derived growth factor subunits and receptors in pituitary adenomas. , 1994, The Journal of clinical endocrinology and metabolism.

[186]  L. Lin,et al.  Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. , 1994, Oncogene.

[187]  R. F. Cook,et al.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.

[188]  M. Bhargava,et al.  Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor , 1994, International journal of cancer.

[189]  A. Bardelli,et al.  A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.

[190]  Michael J. Eck,et al.  Structure of the regulatory domains of the Src-family tyrosine kinase Lck , 1994, Nature.

[191]  Hong Zhu,et al.  Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[192]  T. Nakamura,et al.  Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. , 1994, Oncogene.

[193]  M. Ogawa,et al.  Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. , 1994, Cancer research.

[194]  J. Richie,et al.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.

[195]  J. Burthem,et al.  The function of c-fms in hairy-cell leukemia: macrophage colony- stimulating factor stimulates hairy-cell movement , 1994 .

[196]  T. H. van der Kwast,et al.  Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo. , 1994, Cancer genetics and cytogenetics.

[197]  E. Shinbrot,et al.  Expression of the platelet‐derived growth factor β receptor during organogenesis and tissue differentiation in the mouse embryo , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[198]  S. Parsons,et al.  pp60c‐src Enhances the Acetylcholine Receptor‐Dependent Catecholamine Release in Vaccinia Virus‐Infected Bovine Adrenal Chromaffin Cells , 1994, Journal of neurochemistry.

[199]  M. Resh,et al.  Myristylation and palmitylation of Src family members: The fats of the matter , 1994, Cell.

[200]  B. Zetter,et al.  Regulation of chemotaxis by the platelet-derived growth factor receptor-β , 1994, Nature.

[201]  C. Cartwright,et al.  Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. , 1994, The Journal of clinical investigation.

[202]  M. Luther,et al.  Involvement of pp60c-src with two major signaling pathways in human breast cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[203]  H. DeLisser,et al.  Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties , 1994, The Journal of cell biology.

[204]  W. Muller,et al.  Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity , 1994, Molecular and cellular biology.

[205]  R. Vallee,et al.  Microtubules and Src homology 3 domains stimulate the dynamin GTPase via its C-terminal domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[206]  M. Stoffel,et al.  Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20. , 1993, Blood.

[207]  K. Matsumoto,et al.  Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. , 1993, Oncogene.

[208]  M. Gaffey,et al.  Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. , 1993, Archives of otolaryngology--head & neck surgery.

[209]  I. Campbell,et al.  The GTPase dynamin binds to and is activated by a subset of SH3 domains , 1993, Cell.

[210]  L. Minichiello,et al.  Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF‐dependent mitogenic signals. , 1993, The EMBO journal.

[211]  A. Burgess,et al.  Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. , 1993, The Journal of biological chemistry.

[212]  F. Pontén,et al.  Epithelial-stromal interactions in basal cell cancer: the PDGF system. , 1993, The Journal of investigative dermatology.

[213]  M. Ito,et al.  Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling. , 1993, The Journal of clinical investigation.

[214]  L. Minichiello,et al.  eps15, a novel tyrosine kinase substrate, exhibits transforming activity , 1993, Molecular and cellular biology.

[215]  N. Maihle,et al.  Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases , 1993, Molecular and cellular biology.

[216]  R. Pepperkok,et al.  The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[217]  M. Lisanti,et al.  Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells , 1993, The Journal of cell biology.

[218]  K. Korach,et al.  Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. , 1993, Molecular endocrinology.

[219]  M. Pagano,et al.  Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. , 1993, Oncogene.

[220]  G. Carpenter,et al.  Interaction of activated EGF receptors with coated pit adaptins. , 1993, Science.

[221]  D. Bigner,et al.  Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. , 1993, Cancer research.

[222]  J. Parsons,et al.  The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[223]  T Pawson,et al.  SH2 and SH3 domains , 1993, Current Biology.

[224]  C. Heldin,et al.  Identification of two juxtamembrane autophosphorylation sites in the PDGF beta‐receptor; involvement in the interaction with Src family tyrosine kinases. , 1993, The EMBO journal.

[225]  Nanxin Li,et al.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling , 1993, Nature.

[226]  R. Weinberg,et al.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation , 1993, Nature.

[227]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.

[228]  R. Friesel,et al.  Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. , 1993, The Journal of biological chemistry.

[229]  E. Schuuring,et al.  The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites , 1993, Molecular and cellular biology.

[230]  K. Podratz,et al.  The proto-oncogene c-fms is overexpressed in endometrial cancer. , 1993 .

[231]  M. Mattei,et al.  A novel putative receptor protein tyrosine kinase of the met family. , 1993, Oncogene.

[232]  A. Kazlauskas,et al.  Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal , 1993, Cell.

[233]  T. Pawson,et al.  Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. , 1993, The Journal of biological chemistry.

[234]  W. Birchmeier,et al.  The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells , 1993, The Journal of cell biology.

[235]  M. Sudol,et al.  Proto-oncogenes and signaling processes in neural tissues , 1993, Neurochemistry International.

[236]  G. Neufeld,et al.  Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. , 1993, The Journal of biological chemistry.

[237]  D. Hanahan,et al.  Betacellulin: a mitogen from pancreatic beta cell tumors. , 1993, Science.

[238]  J. Parsons,et al.  Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex , 1993, The Journal of cell biology.

[239]  Y. Miller,et al.  Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. , 1993, Current problems in cancer.

[240]  M. Roussel,et al.  Activation of Src family kinases by colony stimulating factor‐1, and their association with its receptor. , 1993, The EMBO journal.

[241]  J. Cawley,et al.  C‐fms protein expression by B‐cells, with particular reference to the hairy cells of hairy‐cell leukaemia , 1993, British journal of haematology.

[242]  S. Werner,et al.  Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. , 1993, Developmental biology.

[243]  R. Dittadi,et al.  Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue. , 1993, British Journal of Cancer.

[244]  D. Barnes,et al.  Expression of the ERBB3 gene product in breast cancer. , 1992, British Journal of Cancer.

[245]  M. Pierotti,et al.  Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. , 1992, Oncogene.

[246]  S. Albelda,et al.  Platelet endothelial cell adhesion molecule, PECAM‐1, modulates cell migration , 1992, Journal of cellular physiology.

[247]  T. Nakamura,et al.  Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor , 1992, Molecular and cellular biology.

[248]  E. Rozengurt,et al.  Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate. , 1992, The Journal of biological chemistry.

[249]  J. Foekens,et al.  Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. , 1992, Cancer research.

[250]  R. Weinberg,et al.  Association between GTPase activators for Rho and Ras families , 1992, Nature.

[251]  G. Staal,et al.  Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. , 1992, Cancer research.

[252]  Umberto Veronesi,et al.  Breast cancer (Third of three parts) , 1992 .

[253]  Anne J. Ridley,et al.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.

[254]  K. Pavelić,et al.  c-fms is present in primary tumours as well as in their metastases in bone marrow. , 1992, International journal of experimental pathology.

[255]  J. Jankowski,et al.  Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. , 1992, Gut.

[256]  T. Pawson,et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.

[257]  H. Varmus,et al.  Association of p60c-src with endosomal membranes in mammalian fibroblasts , 1992, The Journal of cell biology.

[258]  G. Clinton,et al.  Disulfide‐linked and noncovalent dimers of p185HER‐2 in human breast carcinoma cells , 1992, Journal of cellular biochemistry.

[259]  N. Deng,et al.  Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. , 1992, Cancer research.

[260]  B. Gusterson,et al.  Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[261]  M. Caron,et al.  Tyrosine phosphorylation of G protein alpha subunits by pp60c-src. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[262]  Y. Tanaka,et al.  CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion , 1992, The Journal of experimental medicine.

[263]  B. Binder,et al.  Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1. , 1992, Cancer research.

[264]  S. Dey,et al.  Characterization of the epidermal growth factor receptor in preimplantation pig conceptuses. , 1992, Developmental biology.

[265]  K. Korach,et al.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[266]  C. James,et al.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[267]  R. Weinberg,et al.  Molecular cloning of cDNAs encoding the GAP-associated protein p190: Implications for a signaling pathway from ras to the nucleus , 1992, Cell.

[268]  P. Humphrey,et al.  Structural alterations of the epidermal growth factor receptor gene in human gliomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[269]  G. Gallick,et al.  Growth Inhibition of Human Colorectal Carcinoma Cell Lines by Tumor Necrosis Factor‐Alpha Correlates with Reduced Activity of pp60c‐src , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[270]  L. Minichiello,et al.  Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. , 1992, The Journal of biological chemistry.

[271]  J. Partanen,et al.  Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF‐7 breast‐cancer cells , 1992, International journal of cancer.

[272]  D M Barnes,et al.  Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? , 1992, European journal of cancer.

[273]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[274]  T. Yamamoto,et al.  CSK: a protein-tyrosine kinase involved in regulation of src family kinases. , 1991, The Journal of biological chemistry.

[275]  Ryoji Yamaguchi,et al.  Abnormal structure of the canine oncogene, related to the human c-yes-1 oncogene, in canine mammary tumor tissue. , 1991, American journal of veterinary research.

[276]  H. Saya,et al.  Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines. , 1991, Oncogene.

[277]  R. Schultz,et al.  Blastocoel expansion in the preimplantation mouse embryo: stimulatory effect of TGF-alpha and EGF. , 1991, Development.

[278]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[279]  A. Bardelli,et al.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. , 1991, The EMBO journal.

[280]  S. L. Aukerman,et al.  Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. , 1991, The Journal of clinical endocrinology and metabolism.

[281]  L. Beex,et al.  Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. , 1991, Cancer research.

[282]  M. Viola,et al.  c-src structure in human cancers with elevated pp60c-src activity. , 1991, British Journal of Cancer.

[283]  T. Hunter,et al.  Tyrosine 706 and 807 phosphorylation site mutants in the murine colony-stimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol-3 kinase but show differential defects in their ability to induce early response gene transcription , 1991, Molecular and cellular biology.

[284]  M. Toi,et al.  Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. , 1991, European journal of cancer.

[285]  D. Knighton,et al.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.

[286]  D. Birnbaum,et al.  BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. , 1991, Oncogene.

[287]  N. Park,et al.  Anchorage-independent growth and the expression of cellular proto-oncogenes in normal human epidermal keratinocytes and in human squamous cell carcinoma cell lines. , 1991, Oral surgery, oral medicine, and oral pathology.

[288]  M. Schartl,et al.  Conservation of structure and expression of the c-yes and fyn genes in lower vertebrates. , 1991, Oncogene.

[289]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[290]  R. Kurzrock,et al.  Expression of the macrophage colony‐stimulating factor and its receptor in gynecologic malignancies , 1991, Cancer.

[291]  J. Milbrandt,et al.  Expression of FGF receptor gene in rat development. , 1991, Development.

[292]  N. Lemoine,et al.  Avoiding Punishment Is Its Own Reward , 1991, British Journal of Cancer.

[293]  J. Rubin,et al.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[294]  G. Michalopoulos,et al.  Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. , 1991, Biochemical and biophysical research communications.

[295]  H. Inoue,et al.  Human cellular src gene product: identification of the myristoylated pp60c-src and blockage of its myristoyl acylation with N-fatty acyl compounds resulted in the suppression of colony formation. , 1990, Biochemical and biophysical research communications.

[296]  A. Harris,et al.  Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[297]  T. Kameda,et al.  Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. , 1990, Cancer research.

[298]  T. Pawson,et al.  Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor , 1990, Molecular and cellular biology.

[299]  M. Nordenskjöld,et al.  Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis. , 1990, Cancer research.

[300]  P. Maness,et al.  Tubulin is phosphorylated at tyrosine by pp60c-src in nerve growth cone membranes , 1990, The Journal of cell biology.

[301]  Parsons Sj,et al.  Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src. , 1990 .

[302]  S. Courtneidge,et al.  Association between the PDGF receptor and members of the src family of tyrosine kinases , 1990, Cell.

[303]  J. Downing,et al.  Structural features of the colony‐stimulating factor 1 receptor that affect its association with phosphatidylinositol 3‐kinase. , 1990, The EMBO journal.

[304]  W. McGuire,et al.  HER-2/neu amplification predicts poor survival in node-positive breast cancer. , 1990, Cancer research.

[305]  L. Yee,et al.  Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. , 1990, The American journal of pathology.

[306]  C. Cordon-Cardo,et al.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.

[307]  P. Humphrey,et al.  Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[308]  W. Wiktor-Jedrzejczak,et al.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[309]  Kazuhiro Yoshida,et al.  pp60c‐src protein kinase activity in human gastric carcinomas , 1990, International journal of cancer.

[310]  D. Morrison,et al.  Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex , 1990, Molecular and cellular biology.

[311]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[312]  D. Morrison,et al.  PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex , 1990, Cell.

[313]  M. Andreeff,et al.  Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants. , 1990, Cancer research.

[314]  J. Milner,et al.  A Hitchhiker’s Guide to the NIEHS Strategic Plan , 1990, British Journal of Cancer.

[315]  B. Mayer,et al.  Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[316]  Jonathan A. Cooper,et al.  Binding of GAP to activated PDGF receptors. , 1990, Science.

[317]  R. Ross,et al.  Platelet-derived growth factor and its role in health and disease. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[318]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[319]  M. Moran,et al.  Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases , 1990, Nature.

[320]  N. Leslie,et al.  Plasminogen activator gene expression is induced by the src oncogene product and tumor promoters. , 1990, The Journal of biological chemistry.

[321]  H. Roels,et al.  The neu‐oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients , 1990, International journal of cancer.

[322]  T. Fleming,et al.  PDGF induction of tyrosine phosphorylation of GTPase activating protein , 1989, Nature.

[323]  L. Cantley,et al.  The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase , 1989, Nature.

[324]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[325]  K. Umezawa,et al.  Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. , 1989, Journal of natural products.

[326]  S. Rhee,et al.  Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[327]  W. Fantl,et al.  Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis , 1989, Molecular and cellular biology.

[328]  Jonathan A. Cooper,et al.  Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins , 1989, Cell.

[329]  S. Mizuno,et al.  Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. , 1989, Biochemical and biophysical research communications.

[330]  S. Steinberg,et al.  Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. , 1989, Cancer research.

[331]  E. Nexo,et al.  The receptor for epidermal growth factor is present in human fetal kidney, liver and lung , 1989, Regulatory Peptides.

[332]  T. Pawson,et al.  The unique insert of cellular and viral fms protein tyrosine kinase domains is dispensable for enzymatic and transforming activities. , 1989, The EMBO journal.

[333]  G. Carpenter,et al.  Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells , 1989, Molecular and cellular biology.

[334]  P. Chambon,et al.  Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding. , 1989, Molecular endocrinology.

[335]  T. Hunter,et al.  Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro , 1989, Cell.

[336]  J. Pipas,et al.  pp60c-src activation in human colon carcinoma. , 1989, The Journal of clinical investigation.

[337]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[338]  J. Rossant,et al.  Expression of the c-fms proto-oncogene and of the cytokine, CSF-1, during mouse embryogenesis. , 1989, Developmental biology.

[339]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[340]  J. Parsons,et al.  pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src , 1989, Molecular and cellular biology.

[341]  S. Coughlin,et al.  Role of phosphatidylinositol kinase in PDGF receptor signal transduction. , 1989, Science.

[342]  S. Kalnicki,et al.  Activity of pp60c-src protein kinase in human breast cancer. , 1989, The Mount Sinai journal of medicine, New York.

[343]  S. Mizuno,et al.  Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1. , 1989, Cancer research.

[344]  B. V. van Oirschot,et al.  Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. , 1989, Cancer research.

[345]  R. Clarke,et al.  The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo. , 1989, Molecular endocrinology.

[346]  D. Rifkin,et al.  In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases , 1989, The Journal of cell biology.

[347]  B. Groner,et al.  Overexpression of the c‐erbB‐2 protein in human breast tumor cell lines , 1989, Journal of cellular biochemistry.

[348]  C. Heldin,et al.  Identification and structural analysis of the A type receptor for platelet-derived growth factor. Similarities with the B type receptor. , 1989, The Journal of biological chemistry.

[349]  B. Angus,et al.  Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. , 1988, British Journal of Cancer.

[350]  N. Simpson.  The map of chromosome 20. , 1988, Journal of medical genetics.

[351]  M. J. van de Vijver,et al.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. , 1988, The New England journal of medicine.

[352]  S. Iacobelli,et al.  Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. , 1988, European journal of cancer & clinical oncology.

[353]  D. Rappolee,et al.  Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos. , 1988, Science.

[354]  F. Fromowitz,et al.  Phenotypic and genetic alterations in pre-cancerous cells in the colon. , 1988, Anticancer research.

[355]  D. Rifkin,et al.  Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis , 1988, The Journal of cell biology.

[356]  P. Walicke.  Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[357]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[358]  E. Vellenga,et al.  Expression of the macrophage colony-stimulating factor and c-fms genes in human acute myeloblastic leukemia cells. , 1988, The Journal of clinical investigation.

[359]  M. Sporn,et al.  Peptide growth factors are multifunctional , 1988, Nature.

[360]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[361]  L. Luttrell,et al.  Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src , 1988, Molecular and cellular biology.

[362]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[363]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[364]  R. Arceci,et al.  Apparent role of the macrophage growth factor, CSF-1, in placental development , 1987, Nature.

[365]  D. Gospodarowicz,et al.  Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. , 1987, The Journal of clinical investigation.

[366]  A. Ullrich,et al.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[367]  N. Rosen,et al.  Analysis of pp60c‐src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells , 1987, Journal of cellular biochemistry.

[368]  F. Auricchio,et al.  Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell‐free system. , 1987, The EMBO journal.

[369]  M. Braun,et al.  Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[370]  J. Parsons,et al.  Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. , 1987, The EMBO journal.

[371]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[372]  N. Rosen,et al.  Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. , 1987, Oncogene research.

[373]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[374]  T. Libermann,et al.  An angiogenic growth factor is expressed in human glioma cells. , 1987, The EMBO journal.

[375]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[376]  T. Kmiecik,et al.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.

[377]  T. Roberts,et al.  Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src , 1987, Cell.

[378]  C. Cartwright,et al.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain , 1987, Cell.

[379]  N. Rosen,et al.  Activation of pp60c-src protein kinase activity in human colon carcinoma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[380]  M. Kraus,et al.  Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms. , 1987, The EMBO journal.

[381]  E. Gelmann,et al.  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. , 1987, Molecular endocrinology.

[382]  A. Teti,et al.  Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions. , 1987, Experimental cell research.

[383]  N. Ling,et al.  Multiple influences of a heparin-binding growth factor on neuronal development , 1987, The Journal of cell biology.

[384]  C. Croce,et al.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[385]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[386]  R. Senior,et al.  Brain-derived growth factor is a chemoattractant for fibroblasts and astroglial cells. , 1986, Biochemical and biophysical research communications.

[387]  P. Cohen,et al.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. , 1986, The Journal of biological chemistry.

[388]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[389]  A. Ullrich,et al.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors , 1986, Nature.

[390]  T. Springer,et al.  Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[391]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.

[392]  H Umezawa,et al.  Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus , 1986, Molecular and cellular biology.

[393]  M. Gessler,et al.  Activation of the pp60c‐src kinase during differentiation of monomyelocytic cells in vitro. , 1986, The EMBO journal.

[394]  J. Brugge,et al.  Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[395]  S. Parsons,et al.  p60c-src activity detected in the chromaffin granule membrane. , 1986, Biochemical and biophysical research communications.

[396]  M. Israel,et al.  Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1 , 1986, Journal of virology.

[397]  J. Bishop,et al.  The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[398]  N. Tamaoki,et al.  Amplification of c-yes-1 proto-oncogene in a primary human gastric cancer. , 1985, Japanese journal of cancer research : Gann.

[399]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[400]  William E. Paterson,et al.  Federal Republic of Germany , 1985, International Journal of Comparative Labour Law and Industrial Relations.

[401]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[402]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[403]  P. Yaciuk,et al.  Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[404]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[405]  J. Wittliff,et al.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.

[406]  I. Verma,et al.  Expression of cellular oncogenes in human malignancies. , 1984, Science.

[407]  H. Rübsamen,et al.  Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. , 1983, Cancer research.

[408]  D. Vorojeikina,et al.  Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation. , 1997, Molecular endocrinology.

[409]  M. Mareel,et al.  Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. , 1997, British Journal of Cancer.

[410]  C. Humblet,et al.  Design of peptidomimetic ligands for the pp60src SH2 domain. , 1997, Bioorganic & medicinal chemistry.

[411]  H. Heinzl,et al.  EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. , 1997, Anticancer research.

[412]  C. Heldin.  Protein tyrosine kinase receptors. , 1996, Cancer surveys.

[413]  S. F. Arnold,et al.  Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. , 1995, Molecular endocrinology.

[414]  M. Melhem,et al.  Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon. , 1995, Gastroenterology.

[415]  E. Rosen,et al.  Scatter factor and angiogenesis. , 1995, Advances in cancer research.

[416]  S. Courtneidge,et al.  Src family protein tyrosine kinases and cellular signal transduction pathways. , 1995, Current opinion in cell biology.

[417]  C T Roberts,et al.  Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. , 1994, Molecular endocrinology.

[418]  M. Hendrix,et al.  RNA genetics of breast cancer: maspin as paradigm. , 1994, Cold Spring Harbor symposia on quantitative biology.

[419]  R. Cardiff,et al.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. , 1994, Genes & development.

[420]  A. Bardelli,et al.  Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). , 1994, Oncogene.

[421]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[422]  E. Pasquale,et al.  Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo. , 1993, Developmental biology.

[423]  S. Curley,et al.  Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. , 1993, The Journal of clinical investigation.

[424]  A. Benabid,et al.  EGF receptor amplification and expression in human brain tumours. , 1992, European journal of cancer.

[425]  S. Werner,et al.  Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. , 1992, Development.

[426]  P Roth,et al.  The biology of CSF-1 and its receptor. , 1992, Current topics in microbiology and immunology.

[427]  R. Halaban,et al.  Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. , 1992, Oncogene.

[428]  S. Courtneidge,et al.  Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. , 1992, Oncogene.

[429]  T. Dingermann,et al.  Expression of oncogenes in human breast cancer specimens. , 1991, Anticancer research.

[430]  S. Rhee.  Inositol phospholipid-specific phospholipase C: interaction of the γ isoform with tyrosine kinase , 1991 .

[431]  K. Nelson,et al.  Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[432]  C. Sherr.  Colony-stimulating factor-1 receptor. , 1990, Blood.

[433]  D. C. Lee,et al.  Expression of Growth Factors and Their Receptors in Development , 1990 .

[434]  C. Cartwright,et al.  Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[435]  C R King,et al.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[436]  T. Fleming,et al.  Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.

[437]  C. Heldin,et al.  Platelet-derived growth factor. Three isoforms that bind to two distinct cell surface receptors. , 1989, Acta oncologica.

[438]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[439]  G. V. Vande Woude,et al.  Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[440]  D. Ingber,et al.  Heparin-binding angiogenesis factors: detection by immunological methods. , 1987, Clinical physiology and biochemistry.

[441]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.

[442]  J. Folkman,et al.  Tumor angiogenesis activity in cells grown in tissue culture. , 1976, Cancer research.